1Ikezoe J, Johkoh T, Kohno N, et al. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis.J Thorac Imag, 1996, 11: 250-259.
3Duncan PE, Griffin JP, Garcia A, et al. Fibrosing alveolitis in polymyositis:a review of histologically confirmed cases. Am J Med, 1974, 57: 621-626.
4Schwarz MI, Matthay RA, Sahn SA, et al. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine, 1976, 55: 89-104.
5Tazelaar HD, Viggiano RW, Pickersgill J, et al. Interstitial lung disease in polymyositis and dermatomyositis. Am Rev Respir Dis,1990, 141: 727-733.
6Schnabel A, Reuter M, Gross WL. Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular disease. Arthritis Rheum, 1998, 41: 1215-1220.
7Sauty A, Rochat T, Schoch OD, et al. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J, 1997, 10: 2907-2912.
8Shinohara T, Hidaka T, Matsuki Y, et al. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Intern Med,1997, 36: 519-523.
9Schwarz MI. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thorac Imag, 1992, 7: 46-54.
10Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis:impact of oxygen and colchicine, prednisone or no therapy on survival. Am J Respir Crit Care Med, 2000, 161: 1172-1178.
